Clinical Trial

[Subject recruitment] A open-label, dose-escalation Phase I trial of PA3-17 injection in adult patients with CD7-positive relapsed/refractory lymphoid hematologic malignancies

Unique Protocol ID: PG-CART-007-001

Brief Title: CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T- lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
Official Title: CD7 CAR-T Cells for Patients With Relapse/Refractory CD7+ NK/T Cell Lymphoma ,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia